{
  "id": "fffc1d0f78fcc4ef",
  "title": "U . S . FDA issues two observations to Cipla arm InvaGen U . S . facility",
  "description": "20260210T063000Z",
  "content": "",
  "source": "thehindu.com",
  "source_url": "https://www.thehindu.com/business/Industry/us-fda-issues-two-observations-to-cipla-arm-invagens-us-facility/article70613952.ece",
  "published_at": "20260210T063000Z",
  "fetched_at": "2026-02-11T00:34:18.892628+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "India",
  "raw_data": {
    "url": "https://www.thehindu.com/business/Industry/us-fda-issues-two-observations-to-cipla-arm-invagens-us-facility/article70613952.ece",
    "url_mobile": "https://www.thehindu.com/business/Industry/us-fda-issues-two-observations-to-cipla-arm-invagens-us-facility/article70613952.ece/amp/",
    "title": "U . S . FDA issues two observations to Cipla arm InvaGen U . S . facility",
    "seendate": "20260210T063000Z",
    "socialimage": "https://th-i.thgim.com/public/news/national/roy2pv/article70614014.ece/alternates/LANDSCAPE_1200/cipla%20invagen-2.jpg",
    "domain": "thehindu.com",
    "language": "English",
    "sourcecountry": "India"
  }
}